Speaker illustration

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)

Member of:

European Society of Cardiology

Peter Libby, MD, is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. He actively practices general and preventive cardiology and vascular medicine. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. He conducts basic and translational research in cardiovascular diseases focusing on inflammatory aspects and vascular biology. Dr. Libby has a particular devotion to translate his basic laboratory studies to pilot and then large-scale clinical cardiovascular outcome trials. Dr. Libby has received numerous awards and recognitions for his research accomplishments, and has received a number of lifetime achievement awards from various organizations.

Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?

Event: ESC Congress 2022

Topic: Inflammation and Immunity

Session type: Satellite Symposium

Thumbnail

The EHJ’s Year in Cardiovascular Medicine 2020: heart failure, valvular heart disease, imaging

Event: ESC Congress 2021 - The Digital Experience

Topic: Training and Education

Session type: Official Joint Session

Thumbnail

Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides

Event: ESC Congress 2021 - The Digital Experience

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Secondary Prevention

Session type: Industry Q&A session

Thumbnail

New concepts and models in cardiovascular risk management (EBAC Accredited)

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

Emerging evidence-based approaches to reduce residual atherosclerotic risk - Ask the experts

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol

Event: ESC CONGRESS 2017

Topic: Atherosclerosis

Session type: Satellite Symposium

Thumbnail

Atherosclerosis, cardiovascular risk factors and secondary prevention: are we making progress?

Event: ESC CONGRESS 2017

Topic: Atherosclerosis

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Lipids in atherosclerosis - Evolving concepts

Event: ESC CONGRESS 2017

Topic: Lipids

Session type: Symposium

Thumbnail

The immune system in cardiovascular disease

Event: ESC CONGRESS 2016

Topic: Inflammation, growth factors and signal transduction-vascular

Session type: Moderated Posters

Thumbnail

This platform is supported by

logo Novo Nordisk